StoneX Group’s BIOATLA INC BCAB Stock Holding History

StoneX Group’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-589	Closed	-$4.74K	–	1473
2026 Q1	$4.74K	Buy	+589	New	+$6.89K	﹤0.01%	885

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

StoneX Group's BCAB Position: Q2 2026 in Review

StoneX Group sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 589 shares — an estimated $4.74K sold.

StoneX Group first reported a position in BCAB in Q1 2026 and held it in 1 quarter. The position peaked at $4.74K in Q1 2026. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

StoneX Group reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
StoneX Group sold 589 BIOATLA INC shares in Q2 2026, an estimated $4.74K.
StoneX Group first reported a position in BIOATLA INC in Q1 2026 and held it in 1 quarter.
StoneX Group's BIOATLA INC position peaked at $4.74K in Q1 2026.
21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.